Page 1 | Search Results | Blood Advances | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

Hemant S. Murthy, Mei-Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly, Ankit Kansagra, Fotios V. Michelis, Taiga Nishihori, Mrinal Patnaik, Muhammad Bilal Abid, Mahmoud Aljurf, Yasuyuki Arai, Ulrike Bacher, Talha Badar, Sherif M. Badawy, Karen Ballen, Minoo Battiwalla, Amer Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I. Brown, Rodrigo Martino, Jean-Yves Cahn, Paul Castillo, Jan Cerny, Saurabh Chhabra, Edward Copelan, Andrew Daly, Bhagirathbhai Dholaria, Miguel Angel Diaz Perez, César O. Freytes, Michael R. Grunwald, Shahrukh Hashmi, Gerhard C. Hildebrandt, Omer Jamy, Jacinth Joseph, Christopher G. Kanakry, Nandita Khera, Maxwell M. Krem, Yachiyo Kuwatsuka, Hillard M. Lazarus, Lazaros J. Lekakis, Hongtao Liu, Dipenkumar Modi, Pashna N. Munshi, Alberto Mussetti, Neil Palmisiano, Sagar S. Patel, David A. Rizzieri, Sachiko Seo, Mithun Vinod Shah, Akshay Sharma, Melhm Sohl, Scott R. Solomon, Matthew Ulrickson, Celalettin Ustun, Marjolein van der Poel, Leo F. Verdonck, John L. Wagner, Trent Wang, Baldeep Wirk, Amer Zeidan, Mark Litzow, Partow Kebriaei, Christopher S. Hourigan, Daniel J. Weisdorf, Wael Saber, Mohamed A. Kharfan-Dabaja

Blood Adv (2023) 7 (22): 7007–7016.

https://doi.org/10.1182/bloodadvances.2023011308

Published: 2023

Includes: Supplemental data

Journal Articles

CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia

Blood Adv (2023) 7 (12): 2699–2708.

https://doi.org/10.1182/bloodadvances.2022009376

Published: 2023

Includes: Supplemental data

Journal Articles

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

Satoshi Nishiwaki, Yu Akahoshi, Mari Morita-Fujita, Hiroaki Shimizu, Naoyuki Uchida, Yukiyasu Ozawa, Takahiro Fukuda, Masatsugu Tanaka, Kazuhiro Ikegame, Shuichi Ota, Yuta Katayama, Satoshi Takahashi, Toshiro Kawakita, Takahide Ara, Makoto Onizuka, Takafumi Kimura, Junji Tanaka, Yoshiko Atsuta, Yasuyuki Arai

Blood Adv (2022) 6 (15): 4558–4569.

https://doi.org/10.1182/bloodadvances.2022008032

Published: 2022

Includes: Supplemental data

Journal Articles

Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma

Makiko Yamasaki-Morita, Yasuyuki Arai, Takashi Ishihara, Tomoko Onishi, Hanako Shimo, Kayoko Nakanishi, Yukiko Nishiyama, Tomoyasu Jo, Hidefumi Hiramatsu, Takaya Mitsuyoshi, Chisaki Mizumoto, Junya Kanda, Momoko Nishikori, Toshio Kitawaki, Keiji Nogami, Akifumi Takaori-Kondo, Miki Nagao, Souichi Adachi

Blood Adv (2022) 6 (14): 4216–4223.

https://doi.org/10.1182/bloodadvances.2022007454

Published: 2022

Includes: Supplemental data

Journal Articles

Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning

Blood Adv (2022) 6 (8): 2618–2627.

https://doi.org/10.1182/bloodadvances.2021005800

Published: 2022

Includes: Multimedia, Supplemental data

Journal Articles

Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT

Blood Adv (2020) 4 (13): 3169–3179.

https://doi.org/10.1182/bloodadvances.2020002007

Published: 2020

Includes: Supplemental data

Journal Articles

Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation

Yasuyuki Arai, Tadakazu Kondo, Kyoko Fuse, Yasuhiko Shibasaki, Masayoshi Masuko, Junichi Sugita, Takanori Teshima, Naoyuki Uchida, Takahiro Fukuda, Kazuhiko Kakihana, Yukiyasu Ozawa, Tetsuya Eto, Masatsugu Tanaka, Kazuhiro Ikegame, Takehiko Mori, Koji Iwato, Tatsuo Ichinohe, Yoshinobu Kanda, Yoshiko Atsuta

Blood Adv (2019) 3 (22): 3626–3634.

https://doi.org/10.1182/bloodadvances.2019000934

Published: 2019

Includes: Supplemental data

NARROW

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma

Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning

Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT

Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation

Email alerts

ASH Publications

American Society of Hematology

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma

Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning

Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT

Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only